STEPHANIE THOMAS: Open Payments
NPI 1013682459 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,602 in 37 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $690 · 2025 $2,602
Food & beverage: $2,602
| Company | Payments | Amount |
|---|---|---|
| AOP Health US, LLC | 2 | $1,770 |
| PFIZER INC. | 5 | $146 |
| Alexion Pharmaceuticals, Inc. | 5 | $127 |
| CSL Behring | 4 | $115 |
| VERTEX PHARMACEUTICALS INCORPORATED | 5 | $107 |
| Aimmune Therapeutics, Inc. | 4 | $94 |
| Ferring Pharmaceuticals Inc. | 2 | $54 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $35 |
| Melinta Therapeutics, LLC | 2 | $32 |
Products named: Rapiblyk, ULTOMIRIS, VYNDAQEL, Kcentra, JOURNAVX, VOWST, REBYOTA, ELIQUIS.
Industry payments across TX — which companies pay providers there.
